Xue, Jing
Wang, Yuxia
Li, Bing
Yu, Songyan
Wang, Anping
Wang, Weiqing
Gao, Zhengnan
Tang, Xulei
Yan, Li
Wan, Qin
Qin, Guijun
Chen, Lulu
Ning, Guang
Mu, Yiming
Funding for this research was provided by:
Chinese Society of Endocrinology, the Key Laboratory for Endocrine and Metabolic Diseases of the Ministry of Health (1994DP131044)
National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology (2012ZX09303006-001)
the National High Technology Research and Development Program of China (863 Program, 2011AA020107)
the National Science and Technology Major Project (No. 2011ZX09307-001-08, the REACTION study)
Article History
Received: 13 December 2020
Accepted: 2 February 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: The research protocol was approved by the Committee on Human Research at Rui-Jin Hospital.
: Before data collection, written informed consent was obtained from all participants.
: The authors declare no competing interests.